CoChat

The DOI matches its Crossref record, with a small difference in title or year; 16 of the 16 references it cites were found in a registry or an index.

Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ‐interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels

Rosenbloom, Joel, Feldman, George, Freundlich, Bruce, Jimenez, Sergio A. · 1986 · Arthritis & Rheumatism

Abstract

The effects of recombinant γ‐interferon (rec γ‐IFN) on collagen production by confluent monolayer cultures of progressive systemic sclerosis (PSS) dermal fibroblasts were studied. Five cell lines obtained from patients with rapidly progressive disease of recent onset were examined. All PSS fibroblast cell lines exhibited increased collagen production when compared with normal skin cell lines. It was found that rec γ‐IFN caused potent inhibition of PSS fibroblast collagen production in a concentration‐dependent manner. Greater than 50% inhibition was observed with as little as 50 antiviral units/ml, and maximal effects were attained at a concentration of 500 units/ml. The rec γ‐IFN caused reproducible inhibition of collagen production by the 5 PSS fibroblast cell lines, ranging from 58.9% to 85.6% of control values. Measurement of type I and type III procollagen messenger RNA (mRNA) levels with specific complementary DNA probes demonstrated a coordinate reduction of >60% in mRNA for both transcripts in rec γ‐IFN‐treated cells, compared with control cells. These findings indicate that rec γ‐IFN can modulate the excessive collagen biosynthesis characteristic of PSS fibroblasts and that this effect can be explained largely by the γ‐IFN‐mediated decrease in specific collagen mRNAs.

Overview

Integrity signals

Registry

Crossref · 10.1002/art.1780290706

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 3

  1. Leroy EC, 1985, Scleroderma (systemic sclerosis), Textbook of Rheumatology, 1183
  2. Brouty‐Boye D, 1980, Inhibitory effects of interferons on cell multiplication, Lymphokine Res, 1, 99
  3. Maniatis T, 1982, Molecular Cloning, 196

Cited by

See all 101

Metadata

Authors
Rosenbloom, J., Feldman, G., Freundlich, B., & Jimenez, S. A.
Affiliations
University of Pennsylvania (US)
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1986-07
Volume
29
Issue
7
Pages
851-856
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2034254900
Cited by
101
References
16
Citations by year
2026: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3
FWCI
6.17
Type
journal article
Language
en
Open access
closed
Locations
  • Arthritis & Rheumatism (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (2r01am019616-08)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
Keywords
interferon-gamma, systemic sclerosis, dermal fibroblasts, collagen synthesis, type I procollagen, type III procollagen, procollagen mRNA, antifibrotic therapy
MeSH terms
Adult, Cell Line, Collagen, Dose-Response Relationship, Drug, Female, Fibroblasts, Humans, Interferon-gamma, Male, Middle Aged, Nucleic Acid Hybridization, Procollagen, Recombinant Proteins, RNA, Messenger, Scleroderma, Systemic, Skin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ‐interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels. https://app.cochat.ai/papers/10.1002/art.1780290706
The paper
Rosenbloom, J., Feldman, G., Freundlich, B., & Jimenez, S. A. (1986). Inhibition of excessive scleroderma fibroblast collagen production by recombinant γ‐interferon: Association with a coordinate decrease in types I and III procollagen messenger RNA levels. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780290706

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.